Veterinary Medicine Information website

Myelovax liofilizāts suspensijas iekšķīgai lietošanai pagatavošanai mājputniem

Not authorised
  • Avian encephalomyelitis virus, strain Calnek 1143, Live

Product identification

Medicine name:
Myelovax liofilizāts suspensijas iekšķīgai lietošanai pagatavošanai mājputniem
Active substance:
  • Avian encephalomyelitis virus, strain Calnek 1143, Live
Target species:
  • Poultry
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Avian encephalomyelitis virus, strain Calnek 1143, Live
    1000.00
    50% Embryo Infective Dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate for oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Poultry
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD02
Authorisation status:
  • Surrendered
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/00/1176
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/10/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/10/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/10/2024